Insulin Glargine Associated With Breast Cancer Risk in T2D
Women who received insulin glargine, compared with neutral protamine Hagedorn insulin, had a higher incidence of breast cancer.
HbA1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes and appears to be more powerful than average HbA1c in predicting all-cause death.
Researchers examined the choroidal layer thickness in eyes of patients with diabetes to compare the findings based on medical history of systemic diabetes treatments and stage of diabetic retinopathy.
Family and friends' autonomy support may lead to better glycemic control by reducing distress among patients with diabetes.